BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1179 related articles for article (PubMed ID: 19714720)

  • 21. [A report from the second symposium on the hots and difficult points during antiviral therapy for chronic hepatitis B].
    Zhu HM; Yuan PG; Zhang DZ
    Zhonghua Gan Zang Bing Za Zhi; 2011 May; 19(5):387-90. PubMed ID: 21972443
    [No Abstract]   [Full Text] [Related]  

  • 22. [Latin American guideline for the management of chronic hepatitis B].
    Gadano A; Daruich J; Cheinquer H; Faimboin H; Pessoa M; Tanno H; Mattos A; Silva M; Paraná R; Galoppo C; Porta G; Garassini M; Ferrandiz J; Dávalos M; Galdame O; Marciano S; Ballerga EG; Bessone F; Hernández N; Fassio E; Poniachik J; Strauss E
    Acta Gastroenterol Latinoam; 2011 Dec; 41(4):340-50. PubMed ID: 22292234
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatitis B virus in children: More therapeutic options-but unknown and known unknowns still present.
    Hadžić N; Bansal S
    Hepatology; 2016 Feb; 63(2):360-2. PubMed ID: 26361247
    [No Abstract]   [Full Text] [Related]  

  • 24. Cyclobut-A and cyclobut-G: broad-spectrum antiviral agents with potential utility for the therapy of AIDS.
    Norbeck DW; Kern E; Hayashi S; Rosenbrook W; Sham H; Herrin T; Plattner JJ; Erickson J; Clement J; Swanson R
    J Med Chem; 1990 May; 33(5):1281-5. PubMed ID: 2329551
    [No Abstract]   [Full Text] [Related]  

  • 25. [Report of the Fourth Symposium on the Hotspots and Challenges in Research of Antiviral Therapy for Chronic Hepatitis B].
    Huang C; Yuan PG; Zhu HM; Peng Z; Zhang DZ
    Zhonghua Gan Zang Bing Za Zhi; 2013 May; 21(5):394-6. PubMed ID: 24052965
    [No Abstract]   [Full Text] [Related]  

  • 26. [The guideline of prevention and treatment for chronic hepatitis B: a 2015 update].
    ; ; Hou JL; lai W
    Zhonghua Gan Zang Bing Za Zhi; 2015 Dec; 23(12):888-905. PubMed ID: 26739464
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment strategy for chronic hepatitis B in Japan].
    Arase Y; Kumada H
    Nihon Rinsho; 2011 May; 69 Suppl 4():475-9. PubMed ID: 22096964
    [No Abstract]   [Full Text] [Related]  

  • 28. AASLD practice guidelines: The past, the present, and the future.
    Merriman RB; Tran TT
    Hepatology; 2016 Jan; 63(1):31-4. PubMed ID: 26565582
    [No Abstract]   [Full Text] [Related]  

  • 29. EASL clinical practice guidelines.
    Holomán J; Glasa J
    J Hepatol; 2009 Oct; 51(4):821-2. PubMed ID: 19576653
    [No Abstract]   [Full Text] [Related]  

  • 30. [Brief introduction of "Treatment algorithm for managing chronic hepatitis B virus infection in the United States: 2021 update"].
    Zhuang H
    Zhonghua Gan Zang Bing Za Zhi; 2022 Feb; 30(2):190-195. PubMed ID: 35359069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What is the best end point for hepatitis B treatment?
    Lai CL; Yuen MF
    Ann Intern Med; 2008 Apr; 148(7):560; author reply 560-1. PubMed ID: 18378952
    [No Abstract]   [Full Text] [Related]  

  • 32. Update on Hepatitis A Management-Reply.
    Desai AN; Kim AY
    JAMA; 2021 Jan; 325(4):401-402. PubMed ID: 33496769
    [No Abstract]   [Full Text] [Related]  

  • 33. Update on Hepatitis A Management.
    Weng MK; Harris AM; Nelson NP
    JAMA; 2021 Jan; 325(4):401. PubMed ID: 33496767
    [No Abstract]   [Full Text] [Related]  

  • 34. [The advances on the treatment of chronic hepatitis B: an update of 2014].
    Zhang W; Jia J; Chan HL
    Zhonghua Gan Zang Bing Za Zhi; 2015 Jan; 23(1):2-4. PubMed ID: 25831565
    [No Abstract]   [Full Text] [Related]  

  • 35. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection.
    European Association For The Study Of The Liver
    J Hepatol; 2012 Jul; 57(1):167-85. PubMed ID: 22436845
    [No Abstract]   [Full Text] [Related]  

  • 36. AASLD guidelines for treatment of chronic hepatitis B.
    Terrault NA; Bzowej NH; Chang KM; Hwang JP; Jonas MM; Murad MH;
    Hepatology; 2016 Jan; 63(1):261-83. PubMed ID: 26566064
    [No Abstract]   [Full Text] [Related]  

  • 37. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update.
    Liaw YF; Kao JH; Piratvisuth T; Chan HL; Chien RN; Liu CJ; Gane E; Locarnini S; Lim SG; Han KH; Amarapurkar D; Cooksley G; Jafri W; Mohamed R; Hou JL; Chuang WL; Lesmana LA; Sollano JD; Suh DJ; Omata M
    Hepatol Int; 2012 Jun; 6(3):531-61. PubMed ID: 26201469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B virus infection.
    Trépo C; Chan HL; Lok A
    Lancet; 2014 Dec; 384(9959):2053-63. PubMed ID: 24954675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity.
    Ott JJ; Stevens GA; Groeger J; Wiersma ST
    Vaccine; 2012 Mar; 30(12):2212-9. PubMed ID: 22273662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.
    ;
    J Hepatol; 2017 Aug; 67(2):370-398. PubMed ID: 28427875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 59.